RJFSA
FBT icon

Raymond James Financial Services Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Raymond James Financial Services Advisors’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$14.9M Sell
86,853
-35,121
-29% -$5.81M 0.02% 680
2024
Q2 		$18.8M Buy
121,974
+2,629
+2% +$394K 0.03% 536
2024
Q1 		$18.4M Sell
119,345
-80,762
-40% -$12.3M 0.03% 541
2023
Q4 		$31.6M Buy
200,107
+28,256
+16% +$4.06M 0.05% 345
2023
Q3 		$25.2M Sell
171,851
-72,870
-30% -$11.1M 0.05% 381
2023
Q2 		$37.5M Sell
244,721
-12,840
-5% -$2M 0.07% 278
2023
Q1 		$39.9M Buy
257,561
+49,211
+24% +$7.73M 0.08% 247
2022
Q4 		$32.1M Buy
208,350
+25,150
+14% +$3.71M 0.06% 282
2022
Q3 		$24.2M Sell
183,200
-24,045
-12% -$3.37M 0.05% 341
2022
Q2 		$28.1M Sell
207,245
-7,131
-3% -$983K 0.06% 311
2022
Q1 		$32M Sell
214,376
-20,497
-9% -$3.03M 0.06% 307
2021
Q4 		$38M Buy
234,873
+33,638
+17% +$5.44M 0.07% 272
2021
Q3 		$33.4M Sell
201,235
-2,533
-1% -$433K 0.07% 286
2021
Q2 		$35.2M Sell
203,768
-29
-0% -$4.79K 0.07% 280
2021
Q1 		$32.7M Sell
203,797
-10,941
-5% -$1.87M 0.07% 274
2020
Q4 		$36.1M Sell
214,738
-67,424
-24% -$10.9M 0.09% 229
2020
Q3 		$44.4M Buy
282,162
+12,739
+5% +$2.08M 0.13% 175
2020
Q2 		$45.2M Buy
269,423
+30,600
+13% +$4.8M 0.14% 150
2020
Q1 		$31.3M Sell
238,823
-9,405
-4% -$1.34M 0.14% 152
2019
Q4 		$36.9M Buy
248,228
+57,160
+30% +$7.85M 0.12% 175
2019
Q3 		$23.6M Sell
191,068
-57,561
-23% -$7.66M 0.09% 245
2019
Q2 		$35M Sell
248,629
-4,611
-2% -$636K 0.13% 165
2019
Q1 		$38.2M Sell
253,240
-4,619
-2% -$665K 0.16% 141
2018
Q4 		$32M Buy
257,859
+21,384
+9% +$2.92M 0.17% 129
2018
Q3 		$37.5M Buy
236,475
+162,144
+218% +$24.5M 0.17% 125
2018
Q2 		$10.4M Buy
74,331
+12,655
+21% +$1.74M 0.05% 368
2018
Q1 		$8.2M Buy
61,676
+3,581
+6% +$489K 0.05% 404
2017
Q4 		$7.24M Buy
58,095
+1,478
+3% +$183K 0.05% 415
2017
Q3 		$7.02M Buy
56,617
+11,051
+24% +$1.31M 0.04% 426
2017
Q2 		$5.2M Buy
45,566
+8,275
+22% +$890K 0.04% 497
2017
Q1 		$3.93M Sell
37,291
-25,025
-40% -$2.51M 0.03% 568
2016
Q4 		$5.66M Buy
62,316
+2,368
+4% +$222K 0.05% 417
2016
Q3 		$5.98M Sell
59,948
-284
-0.5% -$27.9K 0.05% 388
2016
Q2 		$5.39M Sell
60,232
-12,637
-17% -$1.16M 0.05% 392
2016
Q1 		$6.38M Sell
72,869
-251,476
-78% -$22.2M 0.07% 304
2015
Q4 		$36.7M Buy
324,345
+28,088
+9% +$3.02M 0.43% 43
2015
Q3 		$30M Buy
296,257
+215,630
+267% +$25.6M 0.5% 38
2015
Q2 		$10M Buy
80,627
+43,263
+116% +$5.22M 0.71% 22
2015
Q1 		$4.42M Buy
37,364
+2,346
+7% +$265K 0.22% 122
2014
Q4 		$3.57M Buy
35,018
+2,790
+9% +$272K 0.18% 142
2014
Q3 		$2.96M Buy
+32,228
New +$2.8M 0.16% 153
2014
Q2 		– Sell
-34,354
Closed -$2.63M – 512
2014
Q1 		$2.63M Buy
34,354
+2,145
+7% +$167K 0.16% 166
2013
Q4 		$2.23M Buy
32,209
+20,968
+187% +$1.38M 0.14% 189
2013
Q3 		$728K Sell
11,241
-126,329
-92% -$7.99M 0.05% 355
2013
Q2 		$8.01M Buy
+137,570
New +$7.86M 0.23% 92

Other funds holding FBT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Raymond James Financial Services Advisors's FBT Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 29% in Q3 2024, selling an estimated $5.81M and leaving 86,853 shares worth $14.9M. The position accounts for 0.02% of the portfolio, ranked #680.

Raymond James Financial Services Advisors first reported a position in FBT in Q2 2013 and has held it in 45 quarters since. The position peaked at $45.2M in Q2 2020. 257 funds tracked by Wall St. Rank hold FBT as of Q3 2024.

  • Raymond James Financial Services Advisors held 86,853 shares of First Trust NYSE Arca Biotechnology Index Fund worth $14.9M as of Q3 2024.
  • Raymond James Financial Services Advisors sold 35,121 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2024, an estimated $5.81M.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #680 holding.
  • Raymond James Financial Services Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 45 quarters since.
  • Raymond James Financial Services Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $45.2M in Q2 2020.
  • 257 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.